Organization · Venture Capital
DAYLI Venture Capital
DAYLI Venture Capital, now operating as DAYLI Partners, is a venture capital firm based in South Korea, focusing on early-stage investments in bio-healthcare and fintech sectors.
Overview
What DAYLI Venture Capital does
What DAYLI Venture Capital is
DAYLI Venture Capital, now operating as DAYLI Partners, is a venture capital firm based in South Korea, focusing on early-stage investments in bio-healthcare and fintech sectors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2014
- Approximate age
- About 12 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find DAYLI Venture Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
DAYLI Venture Capital as a funder
Investment thesis
DAYLI Partners aims to create sustainable value by investing in bio-healthcare and financial/fintech sectors, leveraging sector expertise to support innovative ventures.
Focus narrative
DAYLI Partners invests primarily in the bio-healthcare and financial services sectors, with a strong emphasis on life sciences, biotechnology, and fintech. The firm aims to identify and nurture next-generation companies that leverage scientific, medical, and financial expertise to drive growth and innovation.
Value beyond capital
DAYLI Partners adds value to its portfolio companies through its extensive network in the bio-healthcare and fintech sectors, providing access to industry expertise, strategic guidance, and potential partnerships. The firm leverages its team's diverse backgrounds in finance, healthcare, and technology to support the growth and success of its investments.
Focus and fit
- Stages
- Growth Equity · Pre-IPO
- Sectors
- Biotech · Healthcare · Fintech · Medical Devices · Diagnostics
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 113
- Recorded notable exits
- Curiox Biosystems
Portfolio context
Notable portfolio companies include Orum Therapeutics, a biotech firm developing degrader-antibody conjugates for oncology; Illimis Therapeutics, focused on therapeutics for Alzheimer’s and immune diseases; and DoctorNow, a digital health company. Other companies in their portfolio include GI Innovation, Y-Biologics, Curiox Biosystems, SURETECH, Innosure, and INFORYOU Financial Services.
Common questions
What to know about DAYLI Venture Capital
Upseed classifies DAYLI Venture Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.